Januvia gets expanded FDA approval

10/17/2007 | Reuters · Wall Street Journal, The

Merck & Co.'s diabetes drug Januvia has obtained regulatory approval for use in combination with the drug metformin and with the class of drugs called sulfonylureas. Merck also added warning labels about reports of allergic reactions to Januvia, which will be allowed as initial therapy in combination with metformin, as an add-on to sulfonylureas and as an add-on to a combination of both a sulfonylurea and metformin.

View Full Article in:

Reuters · Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Corporate Counsel - Healthcare Law Group
South San Francisco, CA
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park